We are live on ! Find out more
GI

GAMMA Investing Portfolio holdings

AUM $2.69B
1-Year Est. Return 42.78%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+42.78%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.17B
AUM Growth
+$164M
Cap. Flow
+$157M
Cap. Flow %
13.37%
Top 10 Hldgs %
25.72%
Holding
3,876
New
301
Increased
2,412
Reduced
769
Closed
99

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$7.19M
2
NVDA icon
NVIDIA
NVDA
+$5.82M
3
MSFT icon
Microsoft
MSFT
+$5.63M
4
AMZN icon
Amazon
AMZN
+$4.37M
5
TSLA icon
Tesla
TSLA
+$3.01M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$1.01M
2
XOM icon
ExxonMobil
XOM
+$802K
3
HCA icon
HCA Healthcare
HCA
+$801K
4
MRO
Marathon Oil Corporation
MRO
+$634K
5
AMGN icon
Amgen
AMGN
+$604K

Sector Composition

Rank Sector Weight
1 Technology 24.89%
2 Financials 12.52%
3 Consumer Discretionary 8.81%
4 Healthcare 7.95%
5 Industrials 7.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CFB
3301
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$182 ﹤0.01%
12
-25
-68% -$414
REAX icon
3302
Real Brokerage
REAX
$466M
$179 ﹤0.01%
39
-153
-80% -$802
RAPP
3303
Rapport Therapeutics
RAPP
$2.18B
$177 ﹤0.01%
+10
New +$222
PUBM icon
3304
PubMatic
PUBM
$810M
$176 ﹤0.01%
12
-196
-94% -$3.04K
FFNW
3305
DELISTED
First Financial Northwest, Inc
FFNW
$174 ﹤0.01%
+8
New +$179
BBCP icon
3306
Concrete Pumping Holdings
BBCP
$491M
$173 ﹤0.01%
+26
New +$160
GNTY
3307
DELISTED
Guaranty Bancshares
GNTY
$173 ﹤0.01%
+5
New +$175
EQBK icon
3308
Equity Bancshares
EQBK
$1.05B
$170 ﹤0.01%
+4
New +$178
INDI icon
3309
indie Semiconductor
INDI
$854M
$170 ﹤0.01%
42
-245
-85% -$1.01K
NMRA icon
3310
Neumora Therapeutics
NMRA
$302M
$170 ﹤0.01%
16
-37
-70% -$443
PTLO icon
3311
Portillo's
PTLO
$321M
$169 ﹤0.01%
18
-80
-82% -$915
BLUE
3312
DELISTED
bluebird bio
BLUE
$158 ﹤0.01%
+19
New +$166
MG icon
3313
Mistras Group
MG
$512M
$154 ﹤0.01%
+17
New +$167
VIRC icon
3314
Virco
VIRC
$96.3M
$154 ﹤0.01%
+15
New +$210
VNDA icon
3315
Vanda Pharmaceuticals
VNDA
$302M
$153 ﹤0.01%
32
-166
-84% -$797
DSP icon
3316
Viant Technology
DSP
$265M
$152 ﹤0.01%
+8
New +$125
ARTV
3317
Artiva Biotherapeutics
ARTV
$551M
$151 ﹤0.01%
+15
New +$180
ALMS
3318
Alumis Inc
ALMS
$3.52B
$149 ﹤0.01%
+19
New +$190
AMPL icon
3319
Amplitude
AMPL
$1.41B
$148 ﹤0.01%
+14
New +$140
METCB icon
3320
Ramaco Resources Class B
METCB
$408M
$148 ﹤0.01%
16
– –
RDW icon
3321
Redwire
RDW
$3.25B
$148 ﹤0.01%
+9
New +$97
ORN icon
3322
Orion Group Holdings
ORN
$418M
$147 ﹤0.01%
+20
New +$145
GRPN icon
3323
Groupon
GRPN
$1.02B
$146 ﹤0.01%
12
-2
-14% -$21
OVLY icon
3324
Oak Valley Bancorp
OVLY
$281M
$146 ﹤0.01%
+5
New +$143
YEXT icon
3325
Yext
YEXT
$574M
$146 ﹤0.01%
23
+21
+1,050% +$153
131 132
133
134 135

Similar funds

MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
HC
Henshaw Capital Woburn, Massachusetts $2.7B AUM 29.67% 1-Year Est. Return
CI
Capital International Los Angeles, California $2.7B AUM 31.08% 1-Year Est. Return
LP
Longaeva Partners Chicago, Illinois $2.7B AUM 37.16% 1-Year Est. Return
TCAM
Turtle Creek Asset Management Toronto, Ontario, Canada $2.67B AUM 0.64% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return

GAMMA Investing's Q4 2024 Portfolio in Review

As of Q4 2024, GAMMA Investing held 3,876 positions worth $1.17B, up 16% from $1.01B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

GAMMA Investing deployed $157M of net new capital in Q4 2024, opening 301 new positions and adding to 2,412 existing holdings. Its largest new stake was iShares China Large-Cap ETF: 7,320 shares worth $223K.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $1.01M trimmed.

  • GAMMA Investing's largest Q4 2024 buy was iShares China Large-Cap ETF: 7,320 shares worth $223K.
  • GAMMA Investing added most to Apple in Q4 2024, an estimated $7.19M increase.
  • GAMMA Investing's biggest Q4 2024 reduction was Johnson & Johnson, cutting an estimated $1.01M.
  • GAMMA Investing fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $634K.
  • GAMMA Investing's ten largest holdings make up 26% of its $1.17B portfolio in Q4 2024.
  • GAMMA Investing opened 301 new positions and closed 99 in Q4 2024.
  • GAMMA Investing's portfolio value rose 16% quarter-over-quarter to $1.17B.

Based on GAMMA Investing's 13F filing for Q4 2024, filed 3 Jan 2025.